Fabrication of Contact Lens Device with Integrated Microtubes for in Situ Extended Drug Delivery for Ocular Disease Treatment

2019 ◽  
Author(s):  
Xiaoke Ding ◽  
Chao Song ◽  
Long Que
Keyword(s):  
Drug Delivery ◽  
Contact Lens ◽  
Ocular Disease ◽  
Disease Treatment

scholarly journals Intelligent wireless theranostic contact lens for close-loop electrical sensing and regulation of glaucoma

2021 ◽  
Author(s):  
Cheng Yang ◽  
Qianni Wu ◽  
Junqing Liu ◽  
Jingshan Mo ◽  
Xiangling Li ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Contact Lens ◽  
Closed Loop ◽  
Cross Coupling ◽  
Frequency Separation ◽  
Wireless Power ◽  
Electrical Sensing ◽  
Size Limits ◽  
First Time

Abstract Engineered closed-loop devices that can wirelessly track intraocular pressure (IOP) and offer feedback-medicine administrations are highly desirable for glaucoma treatments, yet remain difficult to develop. Integrated theranostic systems based on contact lens still confront several challenges, including size limits, requirements of wireless operations, and cross-coupling between multiple functional modulus. Here, for the first time to our knowledge, an integrated wireless theranostic contact lens (WTCL) for in situ electrical sensing and on-demand drug delivery of glaucoma was developed. The WTCL utilized a highly compact circuitry and structural design, which enabled high-degreed integration of IOP sensing and electrically controlled delivery modulus on the curved and limited surface of contact lens. The wireless IOP sensing modulus could ultra-sensitively detect IOP fluctuations, due to the unique cantilever configuration design of LCR circuit with ultra-soft air dielectric film sandwiched between each capacitive sensing plate. The drug delivery modulus employed a highly efficient wireless power transfer circuit, to trigger delivery of anti-glaucoma drug into aqueous chamber via iontophoresis to enhance drug permeation across cornea. The specialized design of frequency separation enabled individual operations of different modules without cross-coupling. The minimally invasive, smart, wireless and closed-loop theranostic features endowed the WTCL as a highly promising system for glaucoma treatments.

scholarly journals Integrated wireless theranostic contact lens for in situ electrical sensing and regulation of glaucoma

2021 ◽  
Author(s):  
Cheng Yang ◽  
Qianni Wu ◽  
Junqing Liu ◽  
Jingshan Mo ◽  
Xiangling Li ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Contact Lens ◽  
Closed Loop ◽  
Cross Coupling ◽  
Frequency Separation ◽  
Wireless Power ◽  
Electrical Sensing ◽  
Size Limits ◽  
First Time

Abstract Engineered closed-loop devices that can wirelessly track intraocular pressure (IOP) and offer feedback-medicine administrations are highly desirable for glaucoma treatments, yet remain difficult to develop. Integrated theranostic systems based on contact lens still confront several challenges, including size limits, requirements of wireless operations, and cross-coupling between multiple functional modulus. Here, for the first time to our knowledge, an integrated wireless theranostic contact lens (WTCL) for in situ electrical sensing and on-demand drug delivery of glaucoma was developed. The WTCL utilized a highly compact circuitry and structural design, which enabled high-degreed integration of IOP sensing and electrically controlled delivery modulus on the curved and limited surface of contact lens. The wireless IOP sensing modulus could ultra-sensitively detect IOP fluctuations, due to the unique cantilever configuration design of LCR circuit with ultra-soft air dielectric film sandwiched between each capacitive sensing plate. The drug delivery modulus employed a highly efficient wireless power transfer circuit, to trigger delivery of anti-glaucoma drug into aqueous chamber via iontophoresis to enhance drug permeation across cornea. The specialized design of frequency separation enabled individual operations of different modules without cross-coupling. The noninvasive, smart, wireless and closed-loop theranostic features endowed the WTCL as a highly promising system for glaucoma treatments.

Scaffolds for Drug Delivery in Tissue Engineering

2008 ◽  
Vol 1 (2) ◽  
pp. 113-123 ◽  
Author(s):  
Vikas V. Gaikwad ◽  
Abasaheb B. Patil ◽  
Madhuri V. Gaikwad
Keyword(s):  
Drug Delivery ◽  
Tissue Engineering ◽  
Heart Diseases ◽  
Cartilage Regeneration ◽  
Tissue Growth ◽  
The Body ◽  
Patient Specific ◽  
In Situ Gel ◽  
Heart Muscle Cells

Scaffolds are used for drug delivery in tissue engineering as this system is a highly porous structure to allow tissue growth.  Although several tissues in the body can regenerate, other tissue such as heart muscles and nerves lack regeneration in adults. However, these can be regenerated by supplying the cells generated using tissue engineering from outside. For instance, in many heart diseases, there is need for heart valve transplantation and unfortunately, within 10 years of initial valve replacement, 50–60% of patients will experience prosthesis associated problems requiring reoperation. This could be avoided by transplantation of heart muscle cells that can regenerate. Delivery of these cells to the respective tissues is not an easy task and this could be done with the help of scaffolds. In situ gel forming scaffolds can also be used for the bone and cartilage regeneration. They can be injected anywhere and can take the shape of a tissue defect, avoiding the need for patient specific scaffold prefabrication and they also have other advantages. Scaffolds are prepared by biodegradable material that result in minimal immune and inflammatory response. Some of the very important issues regarding scaffolds as drug delivery systems is reviewed in this article.

scholarly journals Prevalence of Antimicrobial Resistant Bacteria from Conjunctival Flora in an Eye Infection Prone Breed (Saint Bernard)

Molecules ◽  
2021 ◽  
Vol 26 (8) ◽  
pp. 2219
Author(s):  
George Cosmin Nadăș ◽  
Cristiana Ștefania Novac ◽  
Ioana Adriana Matei ◽  
Cosmina Maria Bouari ◽  
Zoltan Miklos Gal ◽  
...  
Keyword(s):  
Multidrug Resistant ◽  
Ocular Disease ◽  
Resistant Bacteria ◽  
Human Populations ◽  
Disease Treatment ◽  
Pseudomonas Spp ◽  
History Of ◽  
External Sources ◽  
Staphylococcus Spp ◽  
Saint Bernard

The conjunctival bacterial resident and opportunistic flora of dogs may represent a major source of dissemination of pathogens throughout the environment or to other animals and humans. Nevertheless, contamination with bacteria from external sources is common. In this context, the study of the antimicrobial resistance (AMR) pattern may represent an indicator of multidrug resistant (MDR) strains exchange. The present study was focused on a single predisposed breed—Saint Bernard. The evaluated animals were healthy, but about half had a history of ocular disease/treatment. The swabs collected from conjunctival sacs were evaluated by conventional microbiological cultivation and antimicrobial susceptibility testing (AST). The most prevalent Gram-positive was Staphylococcus spp.; regardless of the history, while Gram-negative was Pseudomonas spp.; exclusively from dogs with a history of ocular disease/treatment. Other identified genera were represented by Bacillus, Streptococcus, Trueperella, Aeromonas and Neisseria. The obtained results suggest a possible association between the presence of mixed flora and a history of ocular disease/treatment. A high AMR was generally observed (90%) in all isolates, especially for kanamycin, doxycycline, chloramphenicol and penicillin. MDR was recorded in Staphylococcus spp. and Pseudomonas spp. This result together with a well-known zoonotic potential may suggest an exchange of these strains within animal human populations and the environment.

Sign in / Sign up

Export Citation Format

Share Document